Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 1.46% | 243.82 | 1.3% | $795.90m | |
| IMMU | Immunomedics, Inc. | 0.07% | 85.36 | 11.0% | $697.18m | |
| MRNA | Moderna, Inc. | 6.60% | 69.47 | 0.0% | $666.49m | |
| NVAX | Novavax, Inc. | 10.86% | 113.56 | 96.5% | $629.01m | |
| ILMN | Illumina, Inc. | 4.74% | 299.89 | 3.5% | $582.79m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 62.25 | 1.0% | $574.11m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.98% | 574.06 | 2.7% | $443.39m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.92% | 268.18 | 1.9% | $340.86m | |
| BIIB | Biogen, Inc. | 1.20% | 273.28 | 1.6% | $334.97m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.15% | 114.43 | 2.0% | $285.22m | |
| EXAS | EXACT Sciences Corp. | 3.60% | 97.70 | 20.7% | $257.29m | |
| SRNE | Sorrento Therapeutics, Inc. | 4.84% | 9.64 | 1.5% | $240.99m | |
| VXRT | Vaxart, Inc. | 7.40% | 7.40 | 0.0% | $213.88m | |
| SGEN | Seattle Genetics, Inc. | 3.08% | 184.95 | 6.0% | $212.14m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.02% | 52.40 | 3.0% | $193.58m |
Company Profile
Kezar Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco, California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.